Skip to main content


Welcome to ABRF 2012

Telling a Story

The best scientific communications tell a story: why the work is important and where it might lead, while most of the technology that drives the story is conducted “off stage.” This year’s meeting will focus on the cutting edge technologies that drive these stories, and how to implement these techniques in core facilities. Join us at the premier forum for biomolecular technologies in Orlando, Florida - March 2012.


Don't forget to reserve Disney's Magical Express Transportation, complimentary roundtrip airport transportation and luggage delivery! Bypass baggage claim and avoid the hassle of having to find transportation, as Disney's Magical Express service transports you from Orlando International Airport to Disney's Contemporary Resort, and delivers your bags to your room.

Reserve your transportation now by calling (407) WDW-MAGIC or (407) 939-6244.

ABRF 2012 Award Winner Announced

Sponsored by Waters Corporation

The 2012 ABRF Award recipient is Dr. Alan Marshall. He is being honored for the development of Fourier Transform Ion Cyclotron Resonance (FT-ICR) Mass Spectrometry. Dr. Marshall will be presenting the ABRF Award Lecture on Monday, March 19th during the conference.

ABRF 2012 Plenary Speakers

Saturday, March 17

Dr. Trisha Davis, University of Washington

Dr. Davis has been the director of the Yeast Resource Center (YRC) since 2001. The YRC is an NCRR-funded multidisciplinary center that develops new technologies to discover the functional and structural consequence of protein variation, and includes eight labs (including mass spectrometry, sequence-function relationships, quantitative phenotyping, structure prediction and design, fluorescence microscopy, and computational biology). The YRC collaborates widely (ca. 150 collaborators each year) to disseminate these technologies.

Sunday, March 18

Dr. Ram Sasisekharan, Massachusetts Institute of Technology
Dr. Sasisekharan's research group employs a multidisciplinary strategy to develop tools to study glycans such as the glycosaminoglycans with an ultimate goal towards the development of novel pharmacological approaches to alleviate glycan-mediated disease processes.

Monday, March 19

Dr. Kris Gevaert, Flanders Institute for Biotechnology

Dr. Gevaert's group focuses on the development and applications of proprietary peptide-centric and mass spectrometry-driven proteomics techniques.  In particular, COmbined FRActional DIagonal Chromatography (COFRADIC) can be used to chromatographically isolate a wide variety of peptide classes, followed by mass spectrometric analysis to enable each peptide class to reflect individual aspects of dynamic and complex proteomes.

Tuesday, March 20

Dr. George Church, Harvard University

Dr. Church played an early role in initiating the Human Genome Project, and invented the broadly-applied concepts of molecular multiplexing and tags, homologous recombination methods, and DNA array synthesizers. Technology transfer of automated sequencing & software to Genome Therapeutics Corp. resulted in the first commercial genome sequence, (the human pathogen, Helicobacter pylori) in 1994. This multiplex solid-phase sequencing evolved into polonies (1999), ABI-SOLiD (2005) & open-source (2007). Innovations in DNA reading, writing & allele replacement in cells lead to current research & commercialization in human genomics (Complete Genomics,, 23andme, Knome), synthetic biology (SynBERC, Joule, LS9) & newethics/security strategies.